Literature DB >> 16650819

Cellular disulfide-reducing capacity: an integrated measure of cell redox capacity.

James M May1, Zhi-chao Qu, Deanna J Nelson.   

Abstract

To assess the disulfide reduction capacity of intact cells, EA.hy926 endothelial cells were incubated with alpha-lipoic acid in the presence of 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB). Alpha-lipoic acid was reduced within cells to dihydrolipoic acid, which could be quantified upon efflux from the cells as reduction of DTNB. Uptake of both alpha-lipoic acid and alpha-lipoamide occurred at least in part via a medium chain fatty acid transporter, based on inhibition by octanoate. Alpha-lipoic acid was reduced within cells by pyridine nucleotide-disulfide oxidoreductases, since it is not reduced by GSH and since its reduction was inhibited by carmustine. Nonetheless, reduction was also dependent on the cellular redox environment, since it was inhibited by the redox cycling of menadione, by decreasing intracellular GSH, and by reduction of dehydroascorbate. Together, these results show that alpha-lipoic acid-dependent DTNB reduction provides a simple method to assess the disulfide-reducing capacity of intact cells, especially as determined by pyridine nucleotide-disulfide oxidoreductases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16650819     DOI: 10.1016/j.bbrc.2006.04.065

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Uptake and reduction of alpha-lipoic acid by human erythrocytes.

Authors:  James M May; Zhi-chao Qu; Deanna J Nelson
Journal:  Clin Biochem       Date:  2007-07-05       Impact factor: 3.281

2.  Assessing the reductive capacity of cells by measuring the recycling of ascorbic and lipoic acids.

Authors:  James M May
Journal:  Methods Mol Biol       Date:  2010

Review 3.  Lipoic acid. Kinetics and pluripotent biological properties and derivatives.

Authors:  Panagiotis Theodosis-Nobelos; Georgios Papagiouvannis; Paraskevi Tziona; Eleni A Rekka
Journal:  Mol Biol Rep       Date:  2021-08-22       Impact factor: 2.316

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.